1,214
Views
12
CrossRef citations to date
0
Altmetric
Articles

Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study

, , , , , , , & show all
Pages 297-305 | Received 05 Mar 2020, Accepted 10 May 2020, Published online: 28 May 2020

References

  • Drummond M, Kunisaki K, Huang L, et al. Obstructive lung diseases in HIV: a clinical review and identification of key future research needs. Semin Respir Crit Care Med. 2016;37(2):277–288. doi:10.1055/s-0036-1578801.
  • Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183(3):388–395. doi:10.1164/rccm.201006-0836OC.
  • Morris A, George MP, Crothers K, et al. HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc. 2011;8(3):320–325. doi:10.1513/pats.201006-045WR.
  • Gingo MR, George MP, Kessinger CJ, et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med. 2010;182(6):790–796. doi:10.1164/rccm.200912-1858OC.
  • Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–793. doi:10.1001/jama.296.7.782.
  • World Health Organization (WHO). Fact sheet: HIV treatment and care: what’s new in HIV treatment. Geneva: WHO; 2015.
  • Asiki G, Reniers G, Newton R, et al. Adult life expectancy trends in the era of antiretroviral treatment in rural Uganda (1991–2012)). AIDS. 2016;30(3):487–493. doi:10.1097/QAD.0000000000000930.
  • van Gemert F, Kirenga B, Chavannes N, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3(1):e44–e51. doi:10.1016/S2214-109X(14)70337-7.
  • Siddharthan T, Grigsby M, Morgan B, et al. Prevalence of chronic respiratory disease in urban and rural Uganda. Bull World Health Organ. 2019;97(5):318–327. doi:10.2471/BLT.18.216523.
  • North CM, Kakuhikire B, Vořechovská D, et al. Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study. J Glob Health. 2019;9(1):010434.
  • Miller MR, Hankinson J, Brusasco V, Burgos F. ATS/ERS task force: standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
  • Munari AB, Gulart AA, Dos Santos K, et al. Modified Medical Research Council dyspnea scale in GOLD classification better reflects physical activities of daily living. Respir Care. 2018;63(1):77–85. doi:10.4187/respcare.05636.
  • Society AT. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.
  • Jones P, Quirk F, Baveystock C. The St George’s respiratory questionnaire. Respir Med. 1991;85:25–31. doi:10.1016/S0954-6111(06)80166-6.
  • Mirza S, Clay RD, Koslow MA, et al. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–1502.
  • North CM, Allen JG, Okello S, et al. HIV infection, pulmonary tuberculosis, and COPD in rural Uganda: a cross-sectional study. Lung. 2018;196(1):49–57. doi:10.1007/s00408-017-0080-8.
  • North CM, Kakuhikire B, Vořechovská D, et al. Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study. J Glob Health. 2019;9(1):10434.
  • Kunisaki KM, Niewoehner DE, Collins G, et al. Pulmonary function in an international sample of HIV‐positive, treatment‐naïve adults with CD4 counts> 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015;16:119–128. doi:10.1111/hiv.12240.
  • Gupte AN, Wong ML, Msandiwa R, et al. Factors associated with pulmonary impairment in HIV-infected South African adults. PLoS One. 2017;12(9):e0184530. doi:10.1371/journal.pone.0184530.
  • Akanbi MO, Taiwo BO, Achenbach CJ, et al. HIV associated chronic obstructive pulmonary disease in Nigeria. J AIDS Clin Res. 2015;6(5):453. doi:10.4172/2155-6113.1000453.
  • Pefura-Yone E, Fodjeu G, kengne AP, et al. Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking. Respir Med. 2015;109(2):247–254. doi:10.1016/j.rmed.2014.12.003.
  • Gershon AS, Dolmage TE, Stephenson A, et al. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD. 2012;9(3):216–226. doi:10.3109/15412555.2011.648030.
  • Grigsby M, Siddharthan T, Chowdhury MA, et al. socioeconomic status and COPD among low- and middle-income countries . Int J Chron Obstruct Pulmon Dis. 2016;11:2497–2507. doi:10.2147/COPD.S111145.
  • Byrne AL, Marais BJ, Mitnick CD, et al. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015;32:138–146. doi:10.1016/j.ijid.2014.12.016.
  • Ehrlich R, Adams S, Baatjies R, et al. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 2011;15(7):886–891. doi:10.5588/ijtld.10.0526.
  • Jain NK. Chronic obstructive pulmonary disease and tuberculosis. Lung India. 2017;34(5):468–469. doi:10.4103/lungindia.lungindia_183_17.
  • O'Toole RF, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease. Tuberculosis (Edinb). 2015;95(6):659–663. doi:10.1016/j.tube.2015.08.005.
  • Zakaria MW, Moussa HA. Chronic obstructive pulmonary disease in treated pulmonary tuberculous patients. Egypt J Bronchol. 2015;9(1):10.
  • Lee C-H, Lee M-C, Shu C-C, et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect. Dis. 2013;13(1):194. doi:10.1186/1471-2334-13-194.
  • Varkila MR, Vos AG, Barth RE, et al. The association between HIV infection and pulmonary function in a rural African population. PLoS One. 2019;14(1):e0210573. doi:10.1371/journal.pone.0210573.
  • Fitzpatrick ME, Gingo MR, Kessinger C, et al. HIV infection is associated with diffusing capacity impairment in women. J Acquir Immune Defic Syndr. 2013;64(3):284–288.
  • Ronit A, Lundgren J, Afzal S, et al. Airflow limitation in people living with HIV and matched uninfected controls. Thorax. 2018;73(5):431–438. doi:10.1136/thoraxjnl-2017-211079.
  • Drummond MB, Merlo CA, Astemborski J, et al. The effect of HIV infection on longitudinal lung function decline among injection drug users: a prospective cohort. AIDS. 2013;27(8):1303–1311. doi:10.1097/QAD.0b013e32835e395d.
  • Kunisaki KM, Niewoehner DE, Collins G, et al. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. Lancet Respir Med. 2016;4(12):980–989. doi:10.1016/S2213-2600(16)30319-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.